from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1589/bioB

LFCtreatmentdescriptionclass of inhibitor

0.395

Amikacinug/mL Amikacintranslation

0.582

Cap5-10ug/mL Capreomycintranslation

0.348

Rox10-50 ug/mL Roxithromycintranslation

0.989

SM2-5 ug/mL Streptomycintranslation

-0.083

Tet5-10 ug/mL Tetracyclinetranslation

-0.165

Rif0.2-5ug/mL Rifampicintranscription

0.058

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.237

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.472

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.021

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.680

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.083

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.338

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.402

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.528

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.259

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.711

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.019

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.507

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.941

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.141

KCN5-20 ug/mL Potassium cyaniderespiration

-0.267

NaN30.2-2 mM Sodium aziderespiration

0.864

Nigericin50 uM Nigericinrespiration

-0.990

TRC10-150 ug/mL Triclosanrespiration

-2.138

TRZ10-25 ug/mL Thioridazinerespiration

0.827

Valinomycin0.5-10 uM Valinomycinrespiration

0.065

ZnSO42 mM ZnSO4respiration

1.832

menadione6-10 ug/mL Menadionerespiration

-0.377

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.342

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.375

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.276

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.791

NRP_1Non-replicating persistence stage 1dosRassociated

-0.058

Amp0.2mg/mL AmpicillincellWall

-0.192

Cephalexin20-100 ug/mL CephalexincellWall

0.215

Cerulenin0.32-5 ug/mL CerulenincellWall

0.022

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.048

EMB10-20 ug/mL EthambutolcellWall

-0.087

Eta12-40 ug/mL EthionamidecellWall

0.088

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.191

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.507

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.275

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.393

BZA0.12 mg/mL BenzamidearomaticAmides

0.352

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.843

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.630

H2O24 mM hydrogen peroxideDNAdamaging

0.960

Levo10 ug/mL LevofloxacinDNAdamaging

0.217

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.206

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.537

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.466

UVUV-irradiationDNAdamaging

3.134

ARP41-4 ug/mL Antitubercular compound ARP4?

0.506

Antimycin12.5-50 ug/mL Antimycin A?

0.436

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.856

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.389

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.745

PA8240.2-2 ug/mL PA-824?

-0.415

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.394

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.221

Verapamil50 uM Verapamil?

0.748

mercaptoethanol2 mM 2-Mercaptoethanol?

0.703

methoxatin10-20 ug/mL Methoxatin?